The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis - A network meta-analysis

Zhang, L; Guo, L; Wang, L; Jiang, X

Jiang, X (通讯作者)，Sichuan Univ, West China Hosp, Dept Dermatol, Chengdu, Peoples R China.;Jiang, X (通讯作者)，Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Clin Inst Inflammat & Immunol CIII,Lab Dermatol, Chengdu, Peoples R China.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022; 36 (11): 1937

Abstract

Janus kinase (JAK) inhibitors are novel treatment approaches for psoriasis. However, there is no direct comparison of JAK inhibitors in plaque psorias......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索